Press Releases
🇺🇸 FDA Page 13FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 145–156 of 212 articles
Boston Scientific Reports Strong Q1 2026 Results with $5.2 Billion Revenue, 11.6% Growth
FDA Extends Sanofi Sarclisa Subcutaneous Review by Three Months for Multiple Myeloma Treatment
NRx Pharmaceuticals Receives Positive FDA Feedback on Preservative-Free Ketamine Generic Drug Application
Lupin Launches Generic Dapagliflozin-Metformin XR Tablets in US as Xigduo XR Alternative
Sanofi's Tzield Approved by FDA for Children as Young as 1 Year to Delay Type 1 Diabetes Progression
FDA Approves Sanofi's Tzield for Children Age 1+ to Delay Type 1 Diabetes Onset
Francis Medical's Vanquish System Performs First Commercial Prostate Ablation Procedure in Midwest
Aquestive Therapeutics Faces FDA Deficiencies for Anaphylm Drug Application, Class Action Lawsuit Filed
Kyverna's Miv-cel Shows Breakthrough Results in Stiff Person Syndrome Trial, Potentially First Approved Treatment
InVera Medical Reports 90% Vein Closure Success Rate in 12-Month Chronic Venous Disease Trial
Ractigen Therapeutics RAG-17 Shows 81% Reduction in ALS Biomarker in Phase I Trial
Mabwell's Nectin-4 ADC Bulumtatug Fuvedotin Shows Promise in Cervical Cancer Case Report Published in NEJM